Founded in 1958 in Newark, Delaware, this global technology company is recognized for its innovative culture and more than 3,500 unique inventions. Co-development and long qualification timelines create high switching costs for customers and recurring revenue streams. Gore's product portfolio spans high-performance fabrics, such as the well-known GORE-TEX, to critical applications like implantable medical devices, emission-reducing products, and components for space exploration.
Cyborg Score Rationale
Gore demonstrates exceptional operational scale, diversified revenue streams across high-value sectors (medical devices, industrial components, consumer apparel), and entrenched market positions with strong switching costs. However, limited transparency as a private company and exposure to PFAS litigation create headwinds.
Top Insights
With over 13,000 associates and annual revenue of approximately $4.8 billion, it specializes in fluoropolymer technology offering products such as Gore-Tex fabrics, high-performance electronic components, medical devices, and industrial products.
More than 40 million innovative Gore medical devices have been implanted, saving and improving the quality of lives worldwide.
Maryland Attorney General Anthony Brown filed a lawsuit against Delaware-based W.L. Gore & Associates in December 2024, alleging that the company contributed to PFAS contamination through its use of polytetrafluoroethylene (PTFE), including Teflon-branded PTFE, in outdoor wear.
Retail presence via the GORE-TEX label appears in over 50,000 global retail doors; medical and industrial sales follow regulated distribution channels.
Named Competitors
Medtronic medical devices — Cardiac surgery, vascular, and endovascular implants
Abbott vascular products — Implantable medical devices and vascular solutions
Lenzing Plastics advanced polymers — Fluoropolymer and engineered membrane solutions
Donaldson filtration and industrial components — Filtration systems for industrial and transportation markets
Nitto Denko polymers and membranes — High-performance polymers, films, and membrane technologies
Recent Developments
(December 2024) PFAS litigation filed by Maryland Attorney General related to PTFE contamination in outdoor wear
(2025) Continued strategic investments in manufacturing regionalization and ePE R&D for supply resilience
(May 2026) Revenue estimated at $5.3 billion per recent Forbes reporting
Open the full interactive W. L. Gore & Associates, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.